Tvardi Therapeutics Stock Price, News & Analysis
TVRD
NASDAQ
Company Description
Welcome to the overview page for Tvardi Therapeutics (TVRD), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$27.11
-4.94%
1.41
Last updated: June 25, 2025 at 16:00
59.41 %
Performance 1 year
$237.6M
Market Cap
9.4M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Tvardi Therapeutics.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
July 1, 2025
TTI-101 Phase 2 IPF readout
October 1, 2025 - December 31, 2025
Phase 2 data release
Expected topline data from REVERT IPF Phase 2 trial
January 1, 2026
Liver cancer trial preliminary data
Frequently Asked Questions
What is the current stock price of Tvardi Therapeutics (TVRD)?
The current stock price of Tvardi Therapeutics (TVRD) is $28.52 as of June 24, 2025.
What is the market cap of Tvardi Therapeutics (TVRD)?
The market cap of Tvardi Therapeutics (TVRD) is approximately 237.6M.